Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-360 in Narcolepsy Type 1
NCT07633301Phase 2Recruiting
- Sponsor
- Takeda
- Start
- Jun 2026
- Primary completion
- Nov 2027
- Countries
- 7
01
Overview
A Phase 2 trial of TAK-360 in narcolepsy type 1 (NT1), sponsored by Takeda. Started Jun 2026; status: recruiting.
02
Drugs
TAK-360
03
Conditions
narcolepsy type 1 (NT1)
Beyond the preview
Go deeper on NCT07633301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07633301.